Inactive Instrument

News Dermira, Inc.

Equities

US24983L1044

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

QBREXZA Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Payment to Journey Medical Corporation and $7.5 Million to Dermira Inc	22-02-11	CI
Journey Medical Corp completed the acquisition of Qbrexza from Dermira, Inc.	21-04-29	CI
Journey Medical Corp entered into a definitive agreement to acquire Qbrexza from Dermira, Inc. for $160 million.	21-03-30	CI
Evommune, Inc. Enters into an Exclusive License Agreement with Dermira, Inc	21-01-07	CI
Eli Lilly and Company and Dermira Present New Lebrikizumab Phase 2B Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life	20-06-12	CI
Dermira : Form 15-12B - Securities Registration Termination	20-03-02	PU
Dermira : SEC Filing - S-8 POS	20-02-20	PU
Dermira : SEC Filing - POS AM	20-02-20	PU
Dermira, Inc. Announces Board Changes	20-02-20	CI
Dermira : Lilly Completes Acquisition of Dermira	20-02-20	PR
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P Global BMI Index	20-02-20	CI
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P TMI Index	20-02-20	CI
Eli Lilly and Company completed the acquisition of 74.8% stake in Dermira, Inc. from a group of sellers.	20-02-18	CI
Dermira : Statement of Ownership	20-02-10	PU
Dermira : Eli Lilly profit beat helps ease investor concerns over growth	20-01-30	RE
Dermira : Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO	20-01-16	RE
Eli Lilly and : Lilly Announces Agreement to Acquire Dermira	20-01-13	AQ
WeissLaw LLP Investigates Dermira, Inc.	20-01-10	PR
DERMIRA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-01-10	AQ
Dermira : Lilly Announces Agreement to Acquire Dermira	20-01-10	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Dermira, Inc.

Equities

US24983L1044

Summary

Filters